{"DataElement":{"publicId":"2467513","version":"1","preferredName":"Brain Tumor Histopathologic Number Grade","preferredDefinition":"Numeric value to express the degree of abnormality of brain cancer cells, a measure of differentiation and aggressiveness.","longName":"BRAIN_TUM_NUM_GD","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2467509","version":"1","preferredName":"Brain Tumor Histopathologic Grade","preferredDefinition":"Information related to histologic grade or measure of differentiation of a brain tumor.","longName":"BRAIN_TUM_HIST_GD","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2206623","version":"1","preferredName":"Brain Neoplasm","preferredDefinition":"That part of the central nervous system contained within the cranium, comprising the prosencephalon, mesencephalon, and rhombencephalon. It is derived from the anterior part of the embryonic neural tube. Functions include muscle control and coordination, sensory reception and integration, speech production, memory storage, and the elaboration of thought and emotions.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12439:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brain","conceptCode":"C12439","definition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FCF8-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2427327","version":"1","preferredName":"Grade","preferredDefinition":"Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"C18000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05116195-EBA8-7341-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-09","modifiedBy":"ONEDATA","dateModified":"2005-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10862ED1-DADF-3397-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2467511","version":"1","preferredName":"Brain Tumor Number Histopathologic Grade","preferredDefinition":"Numeric values to represent the degree of abnormality of brain cancer cells, a measure of differentiation and aggressiveness.","longName":"BRAIN_TUM_NUM_GD","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":"Well Differentiated","ValueMeaning":{"publicId":"2560440","version":"1","preferredName":"Well Differentiated","longName":"2560440","preferredDefinition":"Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Well Differentiated","conceptCode":"C14171","definition":"Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B925-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2021-03-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10864774-1123-35CE-E044-0003BA3F9857","beginDate":"2006-04-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-03","modifiedBy":"REEVESD","dateModified":"2006-04-03","deletedIndicator":"No"},{"value":"2","valueDescription":"Moderately Differentiated","ValueMeaning":{"publicId":"2559269","version":"1","preferredName":"Moderately Differentiated","longName":"2559269v1.00","preferredDefinition":"Describes tumor cells that have lost some of the appearance of normal cells. They tend to grow and spread at a faster rate than well differentiated tumor cells. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderately Differentiated","conceptCode":"C14162","definition":"Describes tumor cells that have lost some of the appearance of normal cells. They tend to grow and spread at a faster rate than well differentiated tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"2509CE87-B492-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10864774-112F-35CE-E044-0003BA3F9857","beginDate":"2006-04-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-03","modifiedBy":"REEVESD","dateModified":"2006-04-03","deletedIndicator":"No"},{"value":"3","valueDescription":"Poorly Differentiated","ValueMeaning":{"publicId":"2559829","version":"1","preferredName":"Poorly Differentiated","longName":"2559829","preferredDefinition":"Definition not available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Poorly Differentiated","conceptCode":"C14167","definition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B6C2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2009-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10864774-113B-35CE-E044-0003BA3F9857","beginDate":"2006-04-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-03","modifiedBy":"REEVESD","dateModified":"2006-04-03","deletedIndicator":"No"},{"value":"4","valueDescription":"Undifferentiated Histology","ValueMeaning":{"publicId":"2560389","version":"1","preferredName":"Undifferentiated Histology","longName":"2560389v1.00","preferredDefinition":"Describes tumor cells that generally have lost all of the appearance of normal cells. They tend to grow and spread quickly and aggressively._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","context":"PMI","contextVersion":"1","Concepts":[{"longName":"Undifferentiated","conceptCode":"C14176","definition":"Describes tumor cells that generally have lost all of the appearance of normal cells. They tend to grow and spread quickly and aggressively.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"2509CE87-B8F2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2022-08-05","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":"8/5/2022: created for PMI EC form. SL","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10864774-1147-35CE-E044-0003BA3F9857","beginDate":"2006-04-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-03","modifiedBy":"REEVESD","dateModified":"2006-04-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2467510","version":"1","preferredName":"Number Grade","preferredDefinition":"Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.:Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"C25337:C18000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10863E3A-7308-350E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-03","modifiedBy":"ONEDATA","dateModified":"2006-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10863E3A-7319-350E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-03","modifiedBy":"REEVESD","dateModified":"2014-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811715","version":"1","longName":"Duke University","context":"NCIP"},{"publicId":"2812580","version":"1","longName":"Duke 500","context":"NCIP"},{"publicId":"2812582","version":"1","longName":"P1_CPT_BCNU_RD","context":"NCIP"},{"publicId":"2812724","version":"1","longName":"Duke U New CDEs","context":"NCIP"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3886752","version":"1","longName":"For Review","context":"DCI","ClassificationSchemeItems":[{"publicId":"3891931","version":"1","longName":"For Review","context":"DCI"}]}],"AlternateNames":[{"name":"DCI","type":"USED_BY","context":"DCI"}],"ReferenceDocuments":[{"name":"Grade of Histology","type":"Preferred Question Text","description":"Grade of Histology","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"10865041-6726-37D4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-03","modifiedBy":"TSESU","dateModified":"2018-07-16","changeDescription":"Approved by Duke review 5/1/2006.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}